World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000010191
Date of registration: 01/04/2013
Prospective Registration: Yes
Primary sponsor: Juntendo university gradurate school of medicine
Public title: The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease
Scientific title: The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease - The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease
Date of first enrolment: 2013/04/01
Target sample size: 10
Recruitment status: Pending
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011934
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:    
Address:  Japan
Telephone:
Email:
Affiliation:  Juntendo university gradurate school of medicine Department of ermatology
Name:     Atsushi Takagi
Address:  2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan Japan
Telephone:
Email:
Affiliation:  Juntendo university gradurate school of medicine Department of ermatology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1 The patients who have an allergy to celecoxib 2 The patients with the aspirin asthma and gastrointestinal ulceration 3 The patients with serious hepatopathy and nephropathy 4 The patients with the heart disease 5 The patients during the pregnancy or breast-feeding

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Drier's disease Hailey-Hailey disease
Intervention(s)
celecoxib
Primary Outcome(s)
We evaluate it with clinical symptom degree of improvement 1 erythema area 2 erosion area 3 egree of improvement of a pain and itch using a VAS scale
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Juntendo university gradurate school of medicine
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history